CryoPort Inc.

CryoPort Inc provides cryogenic logistics solutions to the life sciences industry. It is a leading supplier of cold chain logistics solutions for biopharmaceutical, IVF, and animal health organizations around the globe, with operations in more than 100 countries. The company was founded in 1999 and has its headquarters in Brentwood, Tennessee. The firm launched as a public company in July 2015 and is listed on the NASDAQ CM. It trades under the ticker CYRX. In December 2020, the CYRX share price showed a 52-week low of $13.01 and a 52-week high of $63.36, with a market cap of $1.95bn. CryoPort Inc completed its first acquisition in May 2019, when it acquired Cryogene, a Texas bio storage company that complements the firm’s primary business. In June of the same year, the company completed a common stock offering that raised $68.8m. CryoPort stock is included in the broad-market Russell 3000® Index and the small-cap Russell 2000® Index. The firm announced a $25m investment from Petrichor Healthcare Capital Management in late 2018 and reported record revenue that year of more than $19m. For more news and real-time updates on the value of this instrument, simply add CYRX stock to your watchlist on eToro.